TAMI MARK

Summary

Affiliation: Thomson Scientific
Country: UK

Publications

  1. ncbi Factors affecting detoxification readmission: analysis of public sector data from three states
    Tami L Mark
    Thomson Medstat, Washington, DC 20008, USA
    J Subst Abuse Treat 31:439-45. 2006
  2. ncbi Evaluation of a tablet PC technology to screen and educate oncology patients
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue, Washington, DC 20008, USA
    Support Care Cancer 16:371-8. 2008
  3. ncbi Mental health treatment expenditure trends, 1986-2003
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue N W, Washington, DC 20008, USA
    Psychiatr Serv 58:1041-8. 2007
  4. ncbi Trends in spending for substance abuse treatment, 1986-2003
    Tami L Mark
    Thomson Healthcare, Washington, DC, USA
    Health Aff (Millwood) 26:1118-28. 2007
  5. ncbi The decline in receipt of substance abuse treatment by the privately insured, 1992-2001
    Tami L Mark
    Medstat, Washington, D C, USA
    Health Aff (Millwood) 23:157-62. 2004
  6. ncbi U.S. spending for mental health and substance abuse treatment, 1991-2001
    Tami L Mark
    Medstat, Washington, DC, USA
    Health Aff (Millwood) . 2005
  7. ncbi Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents
    Tami L Mark
    Thomson Medstat, Washington, DC 20008, USA
    Curr Med Res Opin 21:1347-54. 2005
  8. ncbi Characteristics of U.S. youths with serious emotional disturbance: data from the National Health Interview Survey
    Tami L Mark
    Thomson Medstat, 4301 Connecticut Avenue N W, Suite 330, Washington, D C 20008, USA
    Psychiatr Serv 57:1573-8. 2006
  9. ncbi Characterizing substance abuse programs that treat adolescents
    Tami L Mark
    Department of Research and Policy, Thomson Medstat, Washington, DC 20008, USA
    J Subst Abuse Treat 31:59-65. 2006
  10. doi Mental health and substance abuse spending by age, 2003
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue, NW Suite 330, Washington, DC 20008, USA
    J Behav Health Serv Res 35:279-89. 2008

Research Grants

Detail Information

Publications43

  1. ncbi Factors affecting detoxification readmission: analysis of public sector data from three states
    Tami L Mark
    Thomson Medstat, Washington, DC 20008, USA
    J Subst Abuse Treat 31:439-45. 2006
    ..Detoxification readmission is common in the public sector. Engaging patients in treatment following detoxification may reduce readmission rates and time to readmission...
  2. ncbi Evaluation of a tablet PC technology to screen and educate oncology patients
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue, Washington, DC 20008, USA
    Support Care Cancer 16:371-8. 2008
    ..Specifically, the study determined provider and patient opinions of The PACE System and documented evidence as to whether symptom assessment rates increased after this system was implemented...
  3. ncbi Mental health treatment expenditure trends, 1986-2003
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue N W, Washington, DC 20008, USA
    Psychiatr Serv 58:1041-8. 2007
    ..This study determined spending on mental health treatment in the United States over time by provider and payer relative to all health spending...
  4. ncbi Trends in spending for substance abuse treatment, 1986-2003
    Tami L Mark
    Thomson Healthcare, Washington, DC, USA
    Health Aff (Millwood) 26:1118-28. 2007
    ..S. health care spending grew by 8.0 percent. As a result of the slower growth of SA spending compared to that for all health care, SA spending fell as a share of all health spending from 2.1 percent in 1986 to 1.3 percent in 2003...
  5. ncbi The decline in receipt of substance abuse treatment by the privately insured, 1992-2001
    Tami L Mark
    Medstat, Washington, D C, USA
    Health Aff (Millwood) 23:157-62. 2004
    ..This decline was evident in all categories: inpatient, outpatient, and pharmaceutical usage. Substance abuse spending per covered life (in constant dollars) dropped from about $21.16 in 1992 to about $5.58 in 2001 [corrected]..
  6. ncbi U.S. spending for mental health and substance abuse treatment, 1991-2001
    Tami L Mark
    Medstat, Washington, DC, USA
    Health Aff (Millwood) . 2005
    ..Private insurance payment for substance abuse actually dropped in real dollars, increasing the public share of substance abuse spending...
  7. ncbi Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents
    Tami L Mark
    Thomson Medstat, Washington, DC 20008, USA
    Curr Med Res Opin 21:1347-54. 2005
    ..This study examined dosing and hematologic outcomes with these agents in community oncology clinics...
  8. ncbi Characteristics of U.S. youths with serious emotional disturbance: data from the National Health Interview Survey
    Tami L Mark
    Thomson Medstat, 4301 Connecticut Avenue N W, Suite 330, Washington, D C 20008, USA
    Psychiatr Serv 57:1573-8. 2006
    ..Although it is estimated that serious emotional disturbance affects 9 to 13 percent of children and adolescents in the United States, there are few national data on the characteristics of this group...
  9. ncbi Characterizing substance abuse programs that treat adolescents
    Tami L Mark
    Department of Research and Policy, Thomson Medstat, Washington, DC 20008, USA
    J Subst Abuse Treat 31:59-65. 2006
    ..On a more encouraging note, many facilities were conducting discharge planning and providing aftercare, although the specifics of these services were not determined...
  10. doi Mental health and substance abuse spending by age, 2003
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue, NW Suite 330, Washington, DC 20008, USA
    J Behav Health Serv Res 35:279-89. 2008
    ..SA spending per capita by age was $26 per youth, $98 per mid-age adult, and $28 per older adult...
  11. pmc Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty
    Tami L Mark
    Thomson Healthcare, 4301 Connecticut Avenue, Suite 330, Washington, DC 20008, United States
    Drug Alcohol Depend 99:345-9. 2009
    ..The extent to which substance dependence medications will be adopted by physicians and patients, and marketed by industry, remains uncertain...
  12. ncbi The benefits and challenges of using computer-assisted symptom assessments in oncology clinics: results of a qualitative assessment
    Tami L Mark
    Thomson Reuters, 4301 Connecticut Avenue, NW, Suite 330, Washington, DC 20008, USA
    Technol Cancer Res Treat 7:401-6. 2008
    ..The approach should receive additional research and development attention...
  13. ncbi Trends in mental health insurance benefits and out-of-pocket spending
    David R McKusick
    The MEDSTAT Group, 4301 Connecticut Avenue, NW Suite 330, Washington, DC 20008, USA
    J Ment Health Policy Econ 5:71-8. 2002
    ..Insurance benefits can have a large effect on whether one is able to access health care services. Mental health and substance abuse (MHSA) insurance coverage has typically been less generous than that of general health services...
  14. ncbi Physicians' opinions about medications to treat alcoholism
    Tami L Mark
    Medstat, Washington, DC 20008, USA
    Addiction 98:617-26. 2003
    ..This paper examines physicians' opinions about and use of two alcoholism medications currently approved in the US--disulfiram and naltrexone--and one alcoholism medication--acamprosate--that might be approved...
  15. ncbi Access to new medications to treat schizophrenia
    Tami L Mark
    The MEDSTAT Group, Washington, DC 20008, USA
    J Behav Health Serv Res 29:15-29. 2002
    ..In particular, barriers to access may exist for African Americans. Physician access to information about advances in drug therapies also may play a substantial role in the rate of diffusion of new medications...
  16. ncbi Using stated preference modeling to forecast the effect of medication attributes on prescriptions of alcoholism medications
    Tami L Mark
    Medstat, Washington, DC 20008, USA
    Value Health 6:474-82. 2003
    ..e., efficacy, side effects, compliance, price, mode of administration, method of action)...
  17. ncbi Understanding US addiction physicians' low rate of naltrexone prescription
    Tami L Mark
    The MEDSTAT Group, Washington, DC 20008, USA
    Drug Alcohol Depend 71:219-28. 2003
    ..g. by reading more journal articles about naltrexone) were more likely to prescribe it. In summary, multiple factors are contributing to the relatively low naltexone prescription rate...
  18. ncbi Components of spending for Medicaid Mental Health Services, 2001
    Tami L Mark
    Medstat, Washington, DC, USA
    Psychiatr Serv 56:648. 2005
  19. ncbi The effects of prescription drug copayments on statin adherence
    Teresa B Gibson
    Thomson Medstat, 777 E Eisenhower Parkway, Ann Arbor, MI 48108, USA
    Am J Manag Care 12:509-17. 2006
    ..High copayments may present a barrier to medication adherence among patients with chronic conditions such as hyperlipidemia...
  20. doi For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians
    Tami L Mark
    Thomson Reuters, Washington, DC 20008, USA
    CNS Drugs 24:319-26. 2010
    ..To our knowledge, no prior study has examined the extent to which psychoactive medications are prescribed for non-psychiatric somatic illnesses or the main types of psychiatric disorders for which psychoactive medications are being used...
  21. ncbi What drove private health insurance spending on mental health and substance abuse care, 1992-1999?
    Tami L Mark
    Research and Pharmaceutical Division, Medstat, Washington, DC, USA
    Health Aff (Millwood) 22:165-72. 2003
    ..2 percent of total private insurance spending in 1992 to 5.1 percent in 1999. The decline was attributable to a dramatic decrease in inpatient MH/SA treatment--specifically, the probability of admissions and average length-of-stay...
  22. ncbi Medicaid expenditures on behavioral health care
    Tami L Mark
    MEDSTAT Group, Washington, DC 20008, USA
    Psychiatr Serv 54:188-94. 2003
    ..The authors reviewed studies of Medicaid spending on mental health and substance abuse services...
  23. ncbi Impact of statin copayments on adherence and medical care utilization and expenditures
    Teresa B Gibson
    Thomson Medstat, 777 E Eisenhower Pkwy, Ann Arbor, MI 48108, USA
    Am J Manag Care 12:SP11-9. 2006
    ..To examine the effects of statin cost-sharing (ie, copayments, coinsurance) on adherence to statin medications and the impact of adherence on healthcare utilization and spending...
  24. ncbi The costs of treating persons with depression and alcoholism compared with depression alone
    Tami L Mark
    Medstat, Washington, DC 20008, USA
    Psychiatr Serv 54:1095-7. 2003
  25. doi Future funding for mental health and substance abuse: increasing burdens for the public sector
    Katharine R Levit
    Thomson Reuters, in Evanston, Illinois, USA
    Health Aff (Millwood) 27:w513-22. 2008
    ..For MH, Medicaid is forecasted to fund an increasingly larger share of treatment costs (27 percent), and prescription medications are expected to capture 30 percent of MH spending by 2014...
  26. doi The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures
    Tami L Mark
    Thomson Reuters, 4301 Connecticut Ave, NW, Suite 330, Washington, DC 20008, USA
    Am J Psychiatry 167:1202-9. 2010
    ..Step therapy is not the same as generic substitution...
  27. ncbi Factors associated with the receipt of treatment following detoxification
    Tami L Mark
    Medstat, 4301 Connecticut Avenue, NW, Suite 330, 20008, Washington, DC, USA
    J Subst Abuse Treat 24:299-304. 2003
    ....
  28. ncbi Using stated preference and revealed preference modeling to evaluate prescribing decisions
    Tami L Mark
    Outcomes Research and Econometrics, Medstat, Washington, DC 20008, USA
    Health Econ 13:563-73. 2004
    ....
  29. ncbi Examination of treatment pattern differences by race
    Tami L Mark
    Medstat, 4301 Connecticut Avenue, NW Suite 330, Washington, District of Columbia 20008, USA
    Ment Health Serv Res 5:241-50. 2003
    ..64; CI = 1.27-2.12; p = 0.0002). Schizophrenia is, on average, accompanied by different diagnoses and symptoms in Blacks. Symptom profiles indicate that second-generation antipsychotics may be underprescribed to Black patients...
  30. ncbi Barriers to the use of medications to treat alcoholism
    Tami L Mark
    The MEDSTAT Group, Washington, DC 20008, USA
    Am J Addict 12:281-94. 2003
    ..The study indicates that medications to treat alcoholism must overcome numerous barriers before becoming widely accepted...
  31. ncbi Trends in inpatient detoxification services, 1992-1997
    Tami L Mark
    The MEDSTAT Group, Inc, 4301 Connecticut Avenue NW, Suite 330, Washington, DC 20008, USA
    J Subst Abuse Treat 23:253-60. 2002
    ..2 days and the percentage of admissions through the emergency room increased from 35.6% to 40.1%. Detoxification offers an opportunity to link patients with rehabilitation. This analysis indicates that those opportunities may be missed...
  32. doi Psychiatric discharges in community hospitals with and without psychiatric units: how many and for whom?
    Tami L Mark
    Healthcare and Science Division of Thomson Reuters, 4301 Connecticut Ave, N W, Suite 330, Washington, DC 20008, USA
    Psychiatr Serv 61:562-8. 2010
    ....
  33. ncbi The business case for quality mental health services: why employers should care about the mental health and well-being of their employees
    Ron Z Goetzel
    MEDSTAT Group, Inc, Washington, D C, USA
    J Occup Environ Med 44:320-30. 2002
    ....
  34. doi Productivity losses among treated depressed patients relative to healthy controls
    Suellen Curkendall
    Thomson Reuters, 4301 Connecticut Avenue NW, Suite 330, Washington, DC 20008, USA
    J Occup Environ Med 52:125-30. 2010
    ..Estimate the productivity-related cost of depression in an employed population...
  35. ncbi The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expenditures
    Tami L Mark
    Thomson Reuters, 4301 Connecticut Ave, NW, Ste 330, Washington, DC 20008, USA
    Am J Manag Care 15:123-31. 2009
    ..To examine the effects of antihypertensive step therapy on prescription drug utilization and spending, and other medical care utilization and spending...
  36. doi Smoking cessation: the value of a comprehensive carved-in benefit
    Stephen S Johnston
    Thomson Reuters, Washington, DC 20008, USA
    Am J Health Promot 23:85-7, ii. 2008
    ..Employers may receive a considerable return on the investment of offering SCTs as part of comprehensive insurance benefit for their employees as opposed to a rider...
  37. ncbi Risk adjustment for people with chronic conditions in private sector health plans
    Tami L Mark
    The MEDSTAT Group, Inc, Washington, DC, USA
    Med Decis Making 23:397-405. 2003
    ..Although the problem of adverse selection into more generous health insurance plans has been the focus of previous work, risk adjustment systems have only recently begun to be implemented to blunt its effect...
  38. ncbi Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studies
    Antoine Gosselin
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Clin Ther 28:1701-8. 2006
    ..Several drug administration regimens of epoetin alfa (EPO) and darbepoetin alfa (DARB) are used for the management of anemia in cancer patients in the clinical practice setting...
  39. ncbi Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease
    Lisa Mucha
    Global Health Outcomes and Assessment, Wyeth Research, 500 Arcola Rd, Collegeville, PA 19426, USA
    J Manag Care Pharm 14:451-61. 2008
    ..However, the characteristic declines in learning and memory seen in AD may erode the patient's ability to adhere to medication regimens with or without caregiver support...
  40. ncbi National spending on mental health and substance abuse treatment by age of clients, 1997
    Henrick J Harwood
    Lewin Group, Falls Church, VA, USA
    J Behav Health Serv Res 30:433-43. 2003
    ..Age-specific estimates enable policymakers, providers, and researchers to design programs and studies more appropriately tailored to specific age groups...
  41. ncbi Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients
    Tami L Mark
    Am J Manag Care 13:S72-9. 2007
    ..The goal of this study was to examine prescription fill patterns of lipid-lowering agents among Medicare/ Medicaid dual-eligible patients by ethnicity...
  42. ncbi Datapoints: State-administered spending on mental health services by type of service
    Jeffrey A Buck
    Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, 6 1061, Rockville, Maryland 20857, USA
    Psychiatr Serv 57:29. 2006
  43. ncbi Relationships between urinalysis testing for substance use, medical expenditures, and the occurrence of injuries at a large manufacturing firm
    Ronald J Ozminkowski
    The MEDSTAT Group, Inc, Ann Arbor, Michigan 48108, USA
    Am J Drug Alcohol Abuse 29:151-67. 2003
    ..Hopefully the results of this study will inform the policy debate over drug testing by focusing on real data, as opposed to supposition or political considerations that seem to dominate many discussions...

Research Grants2

  1. FACTORS AFFECTING USE OF MEDICATION TO TREAT ALCOHOLISM
    TAMI MARK; Fiscal Year: 2001
    ..We propose to collect this information through experts panels and a national survey of physicians specialized in treating substance abuse. ..